The anti-apoptotic BCL2 was higher than the control, which is quite expected in most cancer cell lines, but had a decreasing trend in the treated groups.
← all excerpts
Human Wharton's Jelly Stem Cell Secretions Inhibit Human Leukemic Cell Line K562 <i>in vitro</i> by Inducing Cell Cycle Arrest and Apoptosis.
1
—
—